today announced that data from its Phase 2a TrIuMPH trial of EBX-102-02 in 122 adults with IBS-C has been selected for a late-breaking oral presentation at Digestive Disease Week® (DDW) 2025, to be ...

EnteroBiotix Announces Oral Presentation of Phase 2a IBS-C Results at Digestive Disease Week® 2025 Glasgow, Scotland - 28 April 2025. EnteroBiotix Limited ('EnteroBiotix'), a biopharmaceutical ...

The acceptance of our results for an oral presentation also represents an important company milestone, as it reflects the scientific interest we have generated, as recognized by the largest global ...

Data from more than 60 company-sponsored, investigator-sponsored, and collaborative research abstracts, including 9 oral presentations and 6 rapid oral presentations, will be presented across Pfizer’s ...

Submit an oral/paper abstract if you wish to be considered for an oral presentation and associated published paper. A full research paper containing new unpublished results always accompanies oral ...

Internal Drexel community members may view student research abstracts via SharePoint [Link TBA]. Must be logged into Microsoft Office 365 account via Drexel Single Sign-On (SSO).

In the folder "point-master", we provide the code for testing our method on PointNet. The code is written based on the code from (PointNet https://github.com ...